Capital World Investors Biocryst Pharmaceuticals Inc Transaction History

Capital World Investors

  • $625 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 18, 2020
SELL
$1.59 - $3.45 $4.52 Million - $9.8 Million
-2,840,000 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$2.5 - $3.73 $6.25 Million - $9.32 Million
2,498,679 Added 732.06%
2,840,000 $8.14 Million
Q2 2019

Aug 14, 2019
BUY
$2.91 - $9.15 $993,244 - $3.12 Million
341,321 New
341,321 $1.29 Million

Others Institutions Holding BCRX

# of Institutions
285
Shares Held
171M
Call Options Held
625K
Put Options Held
739K
View Full List

About BIOCRYST PHARMACEUTICALS INC

BCRX Quotes by TradingView
  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.62B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Capital World Investors Portfolio

Follow Capital World Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital World Investors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email